Avoro Capital Advisors’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-415,999
Closed -$2.02M 50
2020
Q3
$2.02M Hold
415,999
0.03% 45
2020
Q2
$2.62M Hold
415,999
0.05% 44
2020
Q1
$1.6M Hold
415,999
0.05% 42
2019
Q4
$3.15M Sell
415,999
-1
-0% -$6 0.09% 30
2019
Q3
$3.53M Hold
416,000
0.15% 32
2019
Q2
$5.55M Hold
416,000
0.19% 29
2019
Q1
$6.61M Hold
416,000
0.29% 27
2018
Q4
$4.48M Sell
416,000
-105
-0% -$1.53K 0.27% 29
2018
Q3
$6.12M Hold
416,105
0.28% 35
2018
Q2
$6.11M Hold
416,105
0.24% 36
2018
Q1
$6.43M Hold
416,105
0.31% 37
2017
Q4
$8.3M Hold
416,105
0.54% 28
2017
Q3
$8.43M Buy
416,105
+23,333
+6% +$499K 0.65% 28
2017
Q2
$8.19M Buy
392,772
+6,667
+2% +$143K 1.03% 25
2017
Q1
$8.11M Buy
386,105
+117,139
+44% +$2.26M 1.04% 25
2016
Q4
$4.36M Buy
268,966
+30,633
+13% +$561K 0.88% 25
2016
Q3
$5.33M Buy
+238,333
New +$5.49M 0.93% 27
2015
Q2
Sell
-5,425
Closed -$408K 37
2015
Q1
$408K Sell
5,425
-39,548
-88% -$3.11M 0.16% 33
2014
Q4
$3.39M Buy
+44,973
New +$3.65M 2.3% 17

Other funds holding ALIM

Avoro Capital Advisors's ALIM Position: Q4 2020 in Review

Avoro Capital Advisors sold out of Alimera Sciences (ALIM) in Q4 2020, closing a stake of 415,999 shares — an estimated $2.02M sold.

Avoro Capital Advisors first reported a position in ALIM in Q4 2014 and held it in 19 quarters. The position peaked at $8.43M in Q3 2017. 19 funds tracked by Wall St. Rank hold ALIM as of Q4 2020.

  • Avoro Capital Advisors reported no remaining Alimera Sciences position as of Q4 2020 after selling out during the quarter.
  • Avoro Capital Advisors sold 415,999 Alimera Sciences shares in Q4 2020, an estimated $2.02M.
  • Avoro Capital Advisors first reported a position in Alimera Sciences in Q4 2014 and held it in 19 quarters.
  • Avoro Capital Advisors's Alimera Sciences position peaked at $8.43M in Q3 2017.
  • 19 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2020.

Based on Avoro Capital Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.